Beth Zelnick Kaufman - 16 Dec 2024 Form 4/A - Amendment Insider Report for CorMedix Inc. (CRMD)

Role: Chief Legal Officer
Signature: /s/ Beth Zelnick Kaufman
Issuer symbol: CRMD
Transactions as of: 16 Dec 2024
Net transactions value: -$53,006
Form type: 4/A - Amendment
Filing time: 18 Dec 2024, 16:22:34 UTC
Date Of Original Report: 12 Dec 2024
Previous filing: 16 Dec 2024
Next filing: 06 Jan 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CRMD	Common Stock	Tax liability	$53,006	-6,044	-12%	$8.77	43,956	12 Dec 2024	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reporting person has filed this amendment to restate the transaction reported in the Form 4 filed December 16, 2024 in order to correct the amount of Common Stock beneficially owned by the reporting person following the transaction and to remove a duplicative reference to the Restricted Stock Units reported in Table II. As reported in this amendment, the reporting person directly beneficially owns 43,956 shares of Common Stock following the reported transaction.

Content

The reporting person has filed this amendment to restate the transaction reported in the Form 4 filed December 16, 2024 in order to correct the amount of Common Stock beneficially owned by the reporting person following the transaction and to remove a duplicative reference to the Restricted Stock Units reported in Table II. As reported in this amendment, the reporting person directly beneficially owns 43,956 shares of Common Stock following the reported transaction.